US Patent 11912723 KRAS modulators and uses thereof
Patent 11912723 was granted and assigned to Quanta Therapeutics, Inc. on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+18 properties)
Article (+288 characters)
US Patent 11912723 KRAS modulators and uses thereof
Article
Patent abstract
Provided herein are KRAS modulating compounds, such as compounds of Formula (I), (II), (II*), (III) or pharmaceutically acceptable salts, solvates, stereoisomers, atom labelled, or tautomers of any of the foregoing, useful for modulating KRAS GD12 and/or other G12 mutants.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Audrey Hospital0
Hong Lin0
Juan Luengo0
Neil Johnson0
Date of Patent
February 27, 2024
0Patent Application Number
183625760
Date Filed
July 31, 2023
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11912723 KRAS modulators and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
